阿尼卡医疗 ANIK 深 沪
等待开盘 10-07 09:30:00 美东时间
19.26
-0.470
-2.38%
华盛通- 最 高22.525
- 今 开19.73
- 成交量 13.85万股
- 最 低 19.01
- 昨 收 19.73
- 总市值 28.01万
- 52周最高 22.88
- 市盈率 静 68.18
- 换手率 952.30%
- 52周最低 9.0101
- 委 比 -94.39%
- 总股本 1.45万
- 历史最高 75.715
- 量 比 3.22
- 振 幅 17.82%
- 历史最低 1.10
- 每 手 1
- 风险率 4.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Therapeutics granted 2,500 stock options to a new employee at $11.45 per share, vesting annually over three years, under its 2021 Inducement Plan.
2025-06-05 21:00
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
ANI Pharmaceuticals' CEO, Nikhil Lalwani, will present at the 2025 Jefferies Global Healthcare Conference on June 4, 2025, at 2:35pm ET. The live and archived webcast will be available on the Company’s website under the Investors section.
2025-05-27 20:30
ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
ANI Pharmaceuticals announced a Phase 4 clinical trial comparing two dose levels of Purified Cortrophin Gel for treating acute gout flares, evaluating safety and efficacy.
2025-05-22 10:50
